{"schema_version":"secwatch.filing_event.v1","accession":"0001601830-25-000164","form_type":"8-K","ticker":"RXRX","cik":"0001601830","company_name":"RECURSION PHARMACEUTICALS, INC.","filed_at":"2025-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.884914+00:00","generated_at":"2026-05-17T00:17:55.118230+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Recursion appoints Najat Khan as CEO effective Jan 1, 2026; Q3 net loss $162.3M","bullets":["Najat Khan succeeds Chris Gibson as CEO and President effective Jan 1, 2026; Gibson becomes Chairman.","Khan's base salary set at $680K; receives $1M equity now and expected additional $7.5M equity.","Q3 revenue $5.2M (down from $26.1M); net loss $162.3M (vs $95.8M); R&D spend $121.1M.","Cash ~$785M as of Oct 9, 2025; runway through end-2027; raised $387.5M from ATM facility.","Second microglia phenomap accepted by Roche/Genentech triggers $30M milestone; total partner payments exceed $500M."],"urls":{"canonical":"https://secwatch.observer/filing/0001601830-25-000164","json":"https://secwatch.observer/filing/0001601830-25-000164.json","markdown":"https://secwatch.observer/filing/0001601830-25-000164.md","text":"https://secwatch.observer/filing/0001601830-25-000164.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1601830/000160183025000164/0001601830-25-000164-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1601830/000160183025000164/rxrx-20251104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:17:55.118230+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001193125-26-251709","ticker":"CRVL","company_name":"CORVEL CORP","filed_at":"2026-06-01T21:05:42+00:00","headline":"CorVel CEO Michael Combs to become Executive Chair; Sarah Scott appointed CEO and President effective July 1, 2026","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251709","json":"https://secwatch.observer/filing/0001193125-26-251709.json","markdown":"https://secwatch.observer/filing/0001193125-26-251709.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/874866/000119312526251709/0001193125-26-251709-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/874866/000119312526251709/d24231d8k.htm"},"side_by_side_evidence":null},{"accession":"0000105770-26-000080","ticker":"WST","company_name":"WEST PHARMACEUTICAL SERVICES INC","filed_at":"2026-06-01T20:32:30+00:00","headline":"West Pharmaceutical appoints Michel Lagarde as CEO; Green retires, Friel becomes Chair","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000105770-26-000080","json":"https://secwatch.observer/filing/0000105770-26-000080.json","markdown":"https://secwatch.observer/filing/0000105770-26-000080.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/0000105770-26-000080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/wst-20260531.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-251522","ticker":"VRRM","company_name":"VERRA MOBILITY Corp","filed_at":"2026-06-01T20:29:13+00:00","headline":"Verra Mobility CEO David Roberts steps down amid cost realignment; interim CEO Keyser appointed","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251522","json":"https://secwatch.observer/filing/0001193125-26-251522.json","markdown":"https://secwatch.observer/filing/0001193125-26-251522.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1682745/000119312526251522/0001193125-26-251522-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1682745/000119312526251522/d39754d8k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-251467","ticker":"PENG","company_name":"Penguin Solutions, Inc.","filed_at":"2026-06-01T20:17:28+00:00","headline":"Penguin Solutions CFO Nate Olmstead to step down; Aaron Johnson named interim CFO; reaffirms FY2026 guidance at high end","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251467","json":"https://secwatch.observer/filing/0001193125-26-251467.json","markdown":"https://secwatch.observer/filing/0001193125-26-251467.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1616533/000119312526251467/0001193125-26-251467-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1616533/000119312526251467/d104493d8k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-250020","ticker":"NSC","company_name":"NORFOLK SOUTHERN CORP","filed_at":"2026-06-01T13:15:16+00:00","headline":"Norfolk Southern COO John Orr resigns; Brian Barr appointed successor effective June 1","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-250020","json":"https://secwatch.observer/filing/0001193125-26-250020.json","markdown":"https://secwatch.observer/filing/0001193125-26-250020.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/702165/000119312526250020/0001193125-26-250020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/702165/000119312526250020/d91653d8k.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-063165","ticker":"ADTX","company_name":"Aditxt, Inc.","filed_at":"2026-06-01T12:30:22+00:00","headline":"Aditxt names Jeffrey M. Busch Interim CEO; Amro Albanna steps down","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063165","json":"https://secwatch.observer/filing/0001213900-26-063165.json","markdown":"https://secwatch.observer/filing/0001213900-26-063165.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026063165/0001213900-26-063165-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026063165/ea0292902-8k_aditxt.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-249850","ticker":"RPD","company_name":"Rapid7, Inc.","filed_at":"2026-06-01T12:29:24+00:00","headline":"Rapid7 appoints Wael Mohamed CEO; Corey Thomas becomes Executive Chairman; reaffirms 2026 guidance","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-249850","json":"https://secwatch.observer/filing/0001193125-26-249850.json","markdown":"https://secwatch.observer/filing/0001193125-26-249850.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1560327/000119312526249850/0001193125-26-249850-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1560327/000119312526249850/d109829d8k.htm"},"side_by_side_evidence":null},{"accession":"0001206774-26-000296","ticker":"CLX","company_name":"CLOROX CO /DE/","filed_at":"2026-05-28T20:05:35+00:00","headline":"Clorox CEO Linda Rendle steps down for health reasons; board initiates search","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001206774-26-000296","json":"https://secwatch.observer/filing/0001206774-26-000296.json","markdown":"https://secwatch.observer/filing/0001206774-26-000296.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/21076/000120677426000296/0001206774-26-000296-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/21076/000120677426000296/clx4644261-8k.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}